03908nam 2200589Ia 450 991014527800332120170810190406.01-281-06925-697866110692540-470-69198-00-470-76575-5(CKB)1000000000404383(EBL)320092(OCoLC)476116637(SSID)ssj0000197962(PQKBManifestationID)11179087(PQKBTitleCode)TC0000197962(PQKBWorkID)10161762(PQKB)10670622(MiAaPQ)EBC320092(EXLCZ)99100000000040438320060607d2007 uy 0engur|n|---|||||txtccrMarkers in cardiology[electronic resource] a case-oriented approach /edited by Jesse E. AdamsOxford Blackwell20071 online resource (274 p.)Description based upon print version of record.1-4051-3418-6 Includes bibliographical references and index.Markers in Cardiology : A CASE-ORIENTED APPROACH; Contents; Contributors; Preface; Part 1 Cardiac troponins; 1 Basics of cardiac troponin: practical aspects of assays, potential analytical confounders, and clinical interpretation; 2 Diagnostic use of cardiac troponins in ST-segment elevation myocardial infarction; 3 Therapeutic implications of cardiac troponins in ST-segment elevation and non-ST-segment elevation myocardial infarction; 4 Ischemic heart disease in the absence of overt coronary artery disease; 5 So you think you have a ""false positive'' troponin?6 Use of cardiac troponin in patients in non-ischemic pathologies and exposure to environmental toxins7 Cardiac troponins in patients with congestive heart failure; 8 Troponins and the critically Ill patient; 9 Cardiac troponins and renal failure; 10 Cardiac biomarkers: detection of in-hospital myocardial reinfarction; Part 2 Natriuretic peptides; 11 The future: interpreting new guidelines for myocardial infarction; 12 Basics of natriuretic peptides: practical aspects of assays, potential analytical confounders, and clinical interpretation,; 13 Natriruetic peptides in clinical practice14 Outpatient evaluation for cardiovascular diseases using natriuretic peptide testing15 Natriuretic peptides in patients with renal failure; 16 Congestive heart failure: treatment implications of natriuretic peptides; 17 Utilizing multimarker strategies in patients who present with congestive heart failure; Part 3 Contemporary markers of risk; 18 Clinical integration of C-reactive protein for primary and secondary risk factor stratification; 19 Lipoprotein subfraction analysis using nuclear magnetic resonance spectroscopy; IndexWith the rapid development of the field of cardiac biomarkers comes a need for updated guidance on how to use them clinically. Drs. Adams, Jaffe, and Apple meet that need with this timely reference. Taking a case-oriented approach for the greatest clinical relevance, the book bridges the gap between science and practice. If you use - or want to use - cardiac markers such as BNP and troponin to help your patients, you will find this clear and comprehensive reference provides a dependable source of valuable information. The 19 chapters are divided into three parts: Cardiac TrHeartDiseasesDiagnosisBiochemical markersElectronic books.HeartDiseasesDiagnosis.Biochemical markers.616.1/24616.12Adams Jesse E863206MiAaPQMiAaPQMiAaPQBOOK9910145278003321Markers in cardiology1926919UNINA01782oam 2200565 450 991071406520332120210316121022.0(CKB)5470000002506993(OCoLC)827206019(EXLCZ)99547000000250699320130210d2001 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierThe black population, 2000[electronic resource] percent of population for one or more races[Washington, D.C.] :U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau,2001.1 online resource (2 unnumbered pages) color maps"Issued September 2001.""MSO/01-BP."Black population, 2000 Demographic surveysUnited StatesAfrican AmericansPopulationStatisticsAfrican AmericansStatisticsAfrican AmericansfastAfrican AmericansPopulationfastUnited StatesCensus, 2000United StatesfastCensus data.fastStatistics.fastStatistics.lcgftDemographic surveysAfrican AmericansPopulationAfrican AmericansAfrican Americans.African AmericansPopulation.U.S. Census Bureau,OCLCEOCLCEOCLCOOCLCQOCLCOOCLCQOCLCFGPOBOOK9910714065203321The black population, 20003537063UNINA